Cwestiwn ysgrifenedig WQ93891
- Gofynnwyd gan
- Janet Finch-SaundersCeidwadwyr
- I'w ateb gan
- Cabinet Secretary for Health and Social Care
- Cyflwynwyd
- Dyddiad ateb
- Atebwyd
- Amser i'w ateb
- 6 diwrnod
Cwestiwn
Mae'r cwestiwn a'r ateb yn Saesneg gan nad oes fersiwn Gymraeg ar gael.
What steps is the Cabinet Secretary taking to ensure prompt treatment and ongoing support for individuals with rare skin conditions like morphea?
Ateb
Atebwyd gan Cabinet Secretary for Health and Social Care
Morphoea is a well-recognised condition that we expect general practice to identify and refer to dermatology outpatient care. Patients with mild or very localised disease may be given topical treatments and discharged to primary care for ongoing management. Patients with more widespread disease may be offered other treatments, such as photodynamic therapy, and may require support from specialist dermatology services over the longer term.
The National Planned Care Programme has established a dermatology clinical implementation network to support outpatient service transformation and recovery from the impact of the pandemic.